Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 plus fentanyl for acute abdominal pain in oral opium-addicted patients with suspected lead poisoning
IRCT20150509022181N3Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Abdominal discomfort comparing Fentanyl + placebo with Fentanyl + vitamin B12 (2 arms). Primary endpoints: Pain stop time, Patient satisfaction and 4 more. Started Feb 2018; status: completed.
02
Drugs
cyanocobalaminfentanyl
03
Conditions
Abdominal discomfort
Beyond the preview
Go deeper on IRCT20150509022181N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150509022181N3.